These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas. Kober P; Mossakowska BJ; Rusetska N; Baluszek S; Grecka E; Konopiński R; Matyja E; Oziębło A; Mandat T; Bujko M Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686289 [TBL] [Abstract][Full Text] [Related]
51. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines. Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292 [TBL] [Abstract][Full Text] [Related]
52. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785 [TBL] [Abstract][Full Text] [Related]
53. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study. Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915 [TBL] [Abstract][Full Text] [Related]
55. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study. Cruz-Sánchez FF; Miquel R; Rossi ML; Figols J; Palacín A; Cardesa A Histol Histopathol; 1993 Jan; 8(1):1-8. PubMed ID: 8443419 [TBL] [Abstract][Full Text] [Related]
56. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations. Ely EE; Guzman MA; Calvey LS; Batanian JR Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240 [TBL] [Abstract][Full Text] [Related]
57. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976 [TBL] [Abstract][Full Text] [Related]
58. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Johnson MD; O'Connell M Hum Pathol; 2013 Jun; 44(6):1118-24. PubMed ID: 23317544 [TBL] [Abstract][Full Text] [Related]
59. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas. Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130 [TBL] [Abstract][Full Text] [Related]
60. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]